Postpartum EndometritisMANAGEMENT

OBSTETRIC PRESENTATIONS · 12 SECTIONS

⚲

643 items

☷ Legend

⚲

Cardiovascular Presentations71▾

Respiratory Presentations52▾

Neurological Presentations83▾

Gastrointestinal Presentations74▾

Genitourinary and Reproductive Presentations48▾

Infectious Disease Presentations148▾

Trauma Presentations89▾

Toxicologic Presentations80▾

Psychiatric Presentations26▾

Musculoskeletal and Rheumatologic Presentations96▾

Dermatology Presentations23▾

Environmental and Exposure Presentations27▾

Hematologic and Oncologic Presentations36▾

Pediatric-Specific Presentations19▾

Endocrine and Metabolic Presentations45▾

ENT and Maxillofacial Presentations27▾

Ophthalmologic Presentations19▾

Obstetric Presentations23▾

Chorioamnionitis Eclampsia Ectopic Pregnancy (Ruptured)Ectopic Pregnancy (Unruptured)HELLP Syndrome Hyperemesis gravidarum Peripartum cardiomyopathy Placenta previa Placental abruption Postpartum Endometritis Postpartum hemorrhage Postpartum infection Preeclampsia Preeclampsia-eclampsia Preterm labor Sepsis in pregnancy Septic abortion Shoulder dystocia Spontaneous Abortion (Incomplete)Spontaneous Abortion (Missed)Spontaneous Abortion (Threatened)Threatened-inevitable-incomplete abortion Umbilical cord prolapse

Systemic and Miscellaneous Presentations17▾

01Approach to the Critical Patient/attcp40

Sepsis and hemodynamic instability

›Immediate threat recognition

›Sepsis criteria in postpartum patient

›Fever plus suspected uterine source plus organ dysfunction

›SMFM recommends sepsis workup for any unexplained organ damage postpartum

›Septic shock triggers

›SBP < 90 mmHg or MAP < 65 mmHg

›Lactate >= 2 mmol/l after adequate resuscitation

›If septic shock, IV antibiotics within 1 hour of recognition

›Class I recommendation

›Broad-spectrum coverage immediately

Resuscitation targets

›Hemodynamic goals

›IV fluid resuscitation

›1 to 2 L balanced crystalloid within first 3 hours

›Reassess response after each bolus

›Vasopressor threshold

›Norepinephrine first-line if fluid-refractory hypotension

›Target MAP >= 65 mmHg

›Oxygen supplementation

›SpO2 target >= 95% in postpartum patient

›Escalate if septic pulmonary emboli suspected

›Monitoring bundle

›Continuous cardiac monitor

›Tachycardia >100 beats/min as sepsis marker

›Arrhythmia screen

›Serial lactate measurement

›Repeat at 2 hours if initial >= 2 mmol/l

02History/hx72

Delivery and peripartum details

›Mode of delivery

›Cesarean delivery — strongest risk factor

›Emergency or unplanned cesarean highest risk

›Incidence 10 to 27% post-cesarean vs 1 to 3% vaginal

›Duration of labor

›Prolonged labor increases ascent of vaginal flora

›Rupture of membranes duration

›Prolonged ROM >= 18 hours significant risk factor

›Multiple vaginal exams after membrane rupture

›Intrapartum exposures

›Internal fetal monitoring

›Intrauterine pressure catheter

›Fetal scalp electrode

›Manual placenta removal or uterine instrumentation

›Perioperative antibiotic prophylaxis received

›Cefazolin standard for cesarean

›Azithromycin added in some protocols

›GBS prophylaxis status

›Chorioamnionitis during labor

Symptom onset and fever pattern

›Timing classification

›Early-onset endometritis

›Within 48 hours postpartum

›Typically polymicrobial vaginal flora

›Late-onset endometritis

›48 hours to 6 weeks postpartum

›Raises concern for chlamydia or gonorrhea

03Physical Exam/exam55

Vital signs and general appearance

›Vital sign targets

›Temperature

›>= 38.0 C diagnostic threshold

›>= 38.7 C early high fever criterion

›Heart rate

›Tachycardia >100 beats/min suggests bacteremia or sepsis

›Blood pressure

›Hypotension indicates septic shock

›SBP < 90 mmHg or MAP < 65 mmHg

›Respiratory rate

›Elevation suggests sepsis or pulmonary involvement

›General appearance

›Toxic or ill appearance

›Altered mental status as sepsis indicator

Uterine and abdominal exam

›Uterine assessment

›Uterine fundal tenderness

›Hallmark finding of endometritis

›Assess with gentle palpation

›Uterine subinvolution

›Uterus larger or higher than expected for postpartum day

›Peritoneal signs

›Rebound tenderness

›Guarding suggesting peritonitis or abscess

›Pelvic and speculum exam

›Lochia assessment

›Foul-smelling or purulent discharge

04Differential Diagnosis/ddx48

Life-threatening diagnoses

›Sepsis and septic shock

›Uterine source with systemic organ dysfunction

›ICD-10 O85 puerperal sepsis

›Group A streptococcal puerperal sepsis

›Rapidly progressive and potentially fulminant

›Rash, severe pain, rapid deterioration

›Septic pelvic vein thrombophlebitis

›Persistent fever despite 72 hours of appropriate antibiotics

›May produce septic pulmonary emboli

›Diagnosis of exclusion

›Ovarian vein most commonly involved

›Peritonitis

›Diffuse peritoneal signs on exam

›Complication of severe endometritis

›Uterine dehiscence as alternative cause

›Pulmonary embolism

›Postpartum hypercoagulable state

›Dyspnea, pleuritic pain, tachycardia

›ICD-10 O88.2

Common and important mimics

›Urinary tract infection and pyelonephritis

›Dysuria, frequency, CVA tenderness

›Common postpartum due to catheterization

›ICD-10 O86.20 urinary tract infection

›Surgical site infection

›Cesarean wound erythema and drainage

›Typically days 4 to 7 post-cesarean

05Laboratory Tests/lt48

Core infection and sepsis labs

›Complete blood count with differential

›Leukocytosis supports diagnosis but is nonspecific postpartum

›WBC normally elevated up to 72 hours post-delivery

›Marked elevation with left shift more specific

›Leukopenia as severe sepsis marker

›Thrombocytopenia in septic shock or DIC

›Blood cultures

›Two sets before antibiotics

›Bacteremia in 10 to 20% of endometritis cases

›Do not delay antibiotics more than 45 minutes

›Identifies resistant organisms guiding de-escalation

›Serum lactate

›SMFM recommendation in suspected maternal sepsis

›Elevated >= 2 mmol/l indicates organ hypoperfusion

›Note: lactate physiologically elevated up to 4 mmol/l during labor

›Repeat if initially elevated at 2 hours

Metabolic and organ function labs

›Basic metabolic panel

›Renal function essential for gentamicin dosing

›SCr and estimated GFR baseline

›Creatinine monitoring during once-daily gentamicin

›Electrolytes for sepsis management

›Glucose for stress hyperglycemia management

›Hepatic panel

›Sepsis-associated hepatic dysfunction

›Drug metabolism assessment

›Coagulation studies

06Diagnostic Tests/dt78

Scoring Systems

›Severity stratification framework

›Uncomplicated endometritis

›Fever plus uterine tenderness

›Hemodynamically stable

›No peritoneal signs

›Complicated endometritis

›Persistent fever despite 48 to 72 hours appropriate antibiotics

›Peritoneal signs or pelvic mass

›Hemodynamic instability

›Sepsis or septic shock

›End-organ dysfunction meeting Sepsis-3 criteria

›Vasopressor requirement

›qSOFA in postpartum sepsis screening

›Respiratory rate >= 22 per minute

›Altered mental status

›SBP <= 100 mmHg

›SMFM notes organ dysfunction alone sufficient trigger for sepsis workup

›Do not rely on fever alone

›Diagnostic criteria for endometritis

›Clinical diagnosis does not require scoring tool

›Fever plus uterine tenderness plus delivery within 6 weeks

›Supported by purulent or malodorous lochia

MRI

›MRI pelvis role in postpartum endometritis

›Limited acute utility for routine diagnosis

›Clinical diagnosis does not require MRI

›Motion artifact and availability limitations

›Indications for MRI

›Complex pelvic pathology when CT inconclusive

›Concern for uterine dehiscence after cesarean

›Retained products with inconclusive ultrasound

›MRI superiority for soft tissue characterization

›Abscess wall assessment

›Myometrial involvement extent

›Contraindications

›Hemodynamically unstable patient — CT preferred

›Claustrophobia or non-compatible implants

›CT abdomen and pelvis with contrast

›Indications

›Persistent fever despite 48 to 72 hours of appropriate IV antibiotics

›Peritoneal signs suggesting abscess or peritonitis

›Suspected septic pelvic vein thrombophlebitis

›Wound complication not adequately assessed clinically

›CT findings in endometritis and complications

›Gas within uterine cavity early

›Uterine wall edema or myometritis pattern

›Pelvic abscess as fluid collection with rim enhancement

›Ovarian vein thrombosis as filling defect with vessel enlargement

›Fascial defect or fluid collection at cesarean incision

›CT pulmonary angiography

›Indicated if septic pulmonary emboli or PE suspected

›Dyspnea plus pleuritic pain plus tachycardia in postpartum patient

›Contrast considerations

›Renal function baseline before contrast

›Compatible with breastfeeding — brief pump-and-discard not required per ACR

Ultrasound

›Pelvic ultrasound

›Primary imaging when retained products suspected

›Echogenic material within uterine cavity

›Endometrial thickness > 10 mm with heterogeneous content

›Limitations

›Cannot reliably distinguish endometritis from normal postpartum changes

›False-positive retained products on ultrasound common

›Indications

›Failure to respond to antibiotics at 48 to 72 hours

›Clinical suspicion for retained products

›Pelvic mass on examination

›Doppler assessment

›Ovarian vein thrombosis detection limited by operator dependency

›Color Doppler for vascularity in abscess vs seroma

›Point-of-care ultrasound adjuncts

›Cardiac POCUS in unstable patient

›Left ventricular function gross assessment

›Pericardial effusion exclusion

›IVC assessment

›Fluid responsiveness indicator in resuscitation

›Collapsibility index interpretation

›Lung ultrasound

›Consolidation pattern if pneumonia suspected

›B-lines for pulmonary edema screen

07Disposition/dispo38

Admission criteria

›Inpatient admission indications

›All confirmed or suspected postpartum endometritis

›IV antibiotics required as standard of care

›Oral antibiotics alone insufficient initial therapy

›Sepsis or septic shock

›ICU level care

›Vasopressor therapy

›Peritoneal signs or suspected abscess

›Surgical planning required

›Hemodynamic instability

›SBP < 90 mmHg or MAP < 65 mmHg

›High fever with rigors suggesting bacteremia

›Inability to maintain oral intake

›Level of care determination

›ICU indications

›Vasopressor requirement

›Septic shock with rising lactate

›Respiratory compromise from septic pulmonary emboli

›Multi-organ dysfunction

›Step-down or antepartum unit

›Responding to initial treatment

›Hemodynamically stable

Discharge criteria and follow-up

›Criteria for IV-to-discharge transition

›Afebrile for >= 24 to 48 hours

›No further antipyretic requirement

›Clinically improved uterine tenderness

08Treatment/t82

Initial stabilization

›Sepsis bundle if septic shock criteria met

›IV access

›Two large-bore IV lines

›Consider central access for vasopressor therapy

›Fluid resuscitation

›30 mL/kg balanced crystalloid (lactated Ringer preferred over normal saline)

›Reassess after each 500 mL bolus

›Vasopressor therapy

›Norepinephrine 0.01 to 3 mcg/kg/min titrated to MAP >= 65 mmHg

›First-line vasopressor per surviving sepsis guidelines

›Source control planning

›OB/GYN evaluation for surgical intervention

›D&C if retained products confirmed

›Abscess drainage if pelvic abscess identified

First-line antibiotic regimen

›Clindamycin plus gentamicin (gold standard)

›Clindamycin IV

›900 mg IV every 8 hours

›Anaerobic and gram-positive coverage

›Gentamicin IV once-daily dosing (preferred)

›5 mg/kg IV every 24 hours

›Gram-negative coverage

›Renal function monitoring required

›Trough < 1 mg/L before next dose if once-daily

›Gentamicin IV traditional dosing alternative

›1.5 mg/kg IV every 8 hours

›Peak and trough monitoring

›Cochrane review: clindamycin plus gentamicin superior to other regimens

›94% cure rate with combination

Enterococcal coverage (step-up therapy)

›Add if no improvement at 24 to 48 hours on clindamycin plus gentamicin

›Ampicillin IV

›2 g IV every 6 hours

›Enterococcal and broader streptococcal coverage

›Vancomycin IV (if penicillin allergy)

›15 to 20 mg/kg IV every 8 to 12 hours

›AUC-guided monitoring per institutional protocol

›Target AUC 400 to 600 mg/L per hour

›Triple therapy: clindamycin plus gentamicin plus ampicillin

›Standard escalation for enterococcal coverage

Alternative and single-agent regimens

›Cefoxitin IV

›2 g IV every 6 hours

›Demonstrated noninferiority to traditional multi-drug regimens

›Health-system retrospective study (Bailey et al 2024)

›Broader spectrum beta-lactam monotherapy option

›Ampicillin-sulbactam IV

›3 g IV every 6 hours

›Aerobic and anaerobic coverage

›Renal dose adjustment when creatinine clearance < 30 mL/min

›Piperacillin-tazobactam IV

›3.375 g IV every 6 hours or 4.5 g IV every 8 hours

›Extended infusion over 4 hours per local protocol for severe cases

›Reserved for complicated or refractory cases

›Ertapenem IV

›1 g IV every 24 hours

›Carbapenem option for complex polymicrobial or resistant cases

›Consider in immunocompromised or failed prior regimens

Refractory endometritis management

›Persistent fever at 48 to 72 hours

›Broadened differential evaluation

›CT abdomen and pelvis with contrast

›Wound exploration if cesarean

›MRSA coverage consideration

›Add vancomycin 15 to 20 mg/kg IV if not already included

›Consider linezolid 600 mg IV every 12 hours as alternative

›Septic pelvic vein thrombophlebitis empiric treatment

›Heparin anticoagulation if CT negative and fever persists

›Unfractionated heparin infusion adjusted to aPTT 60 to 100 seconds

›Response within 24 to 48 hours both diagnostic and therapeutic

›Surgical intervention

›Dilation and curettage if retained products confirmed

›Abscess drainage percutaneous or surgical

›Rarely hysterectomy for refractory uterine sepsis

Treatment endpoint and oral step-down

›IV antibiotic duration

›Continue until afebrile >= 24 to 48 hours

›Clinical improvement in uterine tenderness

›Tolerating oral intake

›No fixed duration in uncomplicated cases

›Oral step-down after IV treatment

›NOT recommended for uncomplicated endometritis

›Cochrane review found no benefit from oral follow-on antibiotics

›Level A evidence supporting discontinuation after clinical cure

›Exceptions

›STI-related late-onset endometritis requires oral treatment

›Doxycycline 100 mg PO twice daily for 14 days if chlamydia confirmed

09Special Populations/sp47

Pregnancy

›Antepartum considerations

›Chorioamnionitis versus postpartum endometritis distinction

›Chorioamnionitis is intrapartum uterine infection

›Antibiotics during labor reduce risk of postpartum endometritis

›Antibiotic selection in pregnancy

›Ampicillin plus gentamicin plus metronidazole for chorioamnionitis

›Clindamycin as alternative to metronidazole

›Avoid fluoroquinolones in pregnancy

›Fetal monitoring

›Continuous electronic fetal monitoring during treatment

›Category-specific escalation for non-reassuring tracing

›VTE prophylaxis in antepartum infection

›Elevated thromboembolism risk with chorioamnionitis

›Sequential compression devices

›Low molecular weight heparin if prolonged immobility

›Anticoagulation coordination with delivery planning

Geriatric

›Reproductive age range consideration

›Perimenopause and late reproductive age patients

›Higher baseline comorbidity burden

›Diabetes and obesity more prevalent

›Postpartum endometritis less common > age 35 in context of lower birth rates

›Advanced maternal age associated with higher cesarean delivery rate

›Increased comorbidity complexity

›Modified pharmacologic approach

›Gentamicin dosing in reduced renal function

›Creatinine clearance calculation essential

10Background/b75

Epidemiology

›Incidence and burden

›Vaginal delivery incidence

›1 to 3% of vaginal deliveries

›Most common postpartum infection globally

›Cesarean delivery incidence

›10 to 27% without antibiotic prophylaxis

›Reduced to 3 to 5% with prophylactic cefazolin

›Maternal morbidity contribution

›Major preventable cause of postpartum hospitalization

›Associated with prolonged hospitalization and sepsis

›Microbiology and organisms

›Polymicrobial ascending infection from vaginal flora

›Anaerobic gram-negative bacilli (Bacteroides, Prevotella)

›Anaerobic gram-positive cocci (Peptostreptococcus)

›Aerobic gram-negative bacilli (E. coli, Klebsiella)

›Aerobic gram-positive cocci (GBS, enterococci)

›Ureaplasma urealyticum and Mycoplasma hominis

›Late-onset endometritis microbiology

›Chlamydia trachomatis in 1 to 2% of late-onset cases

›Gonorrhea (Neisseria gonorrhoeae)

Pathophysiology

›Mechanisms of infection

›Ascending contamination pathway

›Cervical dilation during labor allows vaginal flora access

›Labor disrupts cervical mucus barrier

›Internal monitoring devices provide conduit

›Decidual susceptibility

›Devitalized decidua supports bacterial growth

›Devascularized uterine wall post-cesarean

›Blood and devitalized tissue as culture medium

›Cesarean-specific mechanisms

›Uterine incision creates devitalized tissue

›Hematoma formation provides bacterial substrate

›Disruption of normal uterine closure mechanism

›Complication pathways

›Myometritis extension

›Invasion beyond decidua into myometrium

›Necrotizing myometritis in severe cases

›Parametritis and pelvic cellulitis

›Extension through broad ligament

›Uterine wall perforation risk

›Septic pelvic vein thrombophlebitis

›Septic thrombosis of ovarian or other pelvic veins

›Septic emboli to pulmonary vasculature

›Pelvic abscess

›Walled-off infection in cul-de-sac or parametrium

›Requires drainage rather than antibiotics alone

Therapeutic Considerations

›Antibiotic strategy principles

›Broad-spectrum polymicrobial coverage essential

›Single narrow-spectrum agents (ampicillin alone) insufficient

›Must cover aerobic and anaerobic organisms

›No oral step-down for uncomplicated cases

›Cochrane review (Mackeen 2015): oral antibiotics after IV cure provide no benefit

›Reduces total antibiotic exposure and C. difficile risk

›Fluoroquinolones generally avoided

›Limited anaerobic coverage

›Breastfeeding concerns

›Emerging resistance patterns

›Prevention strategies

›Perioperative antibiotic prophylaxis at cesarean

›Cefazolin 2 g IV within 60 minutes of incision

›Azithromycin 500 mg IV addition reduces endometritis by 50% in unplanned cesarean

›Level A evidence for prophylaxis benefit

›Reduction of modifiable risk factors

›Minimizing unnecessary vaginal examinations

›Limiting internal monitoring to indicated cases

›Optimal glycemic control in diabetic patients

›Evidence-based treatment hierarchy

›Clindamycin plus gentamicin remains gold standard

›Cochrane review supporting superiority over alternative regimens

›94% cure rate documented in large series

›Enterococcal coverage step-up at 48 hours if needed

›Ampicillin addition for enterococcal gap in first-line regimen

›Duration driven by clinical response not fixed interval

›Afebrile 24 to 48 hours as endpoint

›No benefit from continuing beyond clinical cure

11Patient Discharge Instructions/pdi33

copy discharge instructions

›Home care for postpartum uterine infection

›Antibiotics as prescribed

›In most cases no oral antibiotics needed after IV treatment completion in hospital

›If prescribed oral antibiotics, take every dose until finished

›Rest and recovery

›Light activity only during recovery period

›Pelvic rest (no intercourse) until cleared by OB/GYN

›Hydration

›Drink plenty of fluids especially water

›Breastfeeding

›Safe to continue breastfeeding during and after treatment

›Discuss with your doctor if infant shows changes in feeding or stool

›Warning signs — return to emergency immediately

›Fever returning after discharge

›Worsening lower abdominal or pelvic pain

›Heavy vaginal bleeding soaking more than one pad per hour

›Foul-smelling vaginal discharge

›Wound changes at cesarean incision

›Increasing redness, swelling, drainage, or opening of wound

›Dizziness, lightheadedness, or feeling faint

›Difficulty breathing or chest pain

›Leg swelling or calf pain (possible blood clot)

›Confusion, severe headache, or difficulty speaking

›Follow-up instructions

›OB/GYN appointment within 1 to 2 weeks of discharge

›Assessment of uterine recovery

›Wound check if post-cesarean

12References/r27

Guidelines and key sources

›Primary clinical references

›Mackeen AD et al. Antibiotic Regimens for Postpartum Endometritis. Cochrane Database of Systematic Reviews 2015

›Gold standard evidence supporting clindamycin plus gentamicin

›Established evidence against routine oral step-down antibiotics

›Duff P. Infection After Cesarean Delivery. American Journal of Obstetrics and Gynecology 2026

›Comprehensive review of pathophysiology, risk factors, and management

›Shields AD et al. SMFM Consult Series No. 67: Maternal Sepsis. AJOG 2023

›Society for Maternal-Fetal Medicine sepsis criteria and management

›Sanchez-Ramos L et al. Prophylactic Antibiotics to Prevent Postcesarean Infection. AJOG 2026

›Evidence for azithromycin addition to cefazolin prophylaxis

›Supporting references

›Bailey P et al. Cefoxitin for Endometritis. Clinical Infectious Diseases 2024

›Noninferiority of cefoxitin monotherapy versus traditional regimens

›Abu Shqara R et al. Low-Grade Fever During Prolonged ROM and Infectious Outcomes. AJOG 2024

›Low-grade intrapartum fever OR 9.0 for subsequent endometritis

›Wang X et al. Development and Validation of a Predictive Model for Postpartum Endometritis. PLoS One 2024

›Bor N et al. Endometritis Following Pregnancy: Comparative Cohort Study with and without RPOC. JOGC 2025

›Lambert KA et al. Antibiotic Recommendations After Postpartum Uterine Exploration. Obstet Gynecol Survey 2023

›Coding references

›ICD-10 O85 puerperal sepsis

›Sepsis following delivery

›ICD-10 O86.0 infection of obstetric surgical wound

›Wound infection post-cesarean

›ICD-10 O86.12 endometritis following delivery

›Primary diagnostic code for postpartum endometritis

›ICD-10 O88.31 pyemic and septic embolism in the puerperium

›Septic pelvic vein thrombophlebitis with emboli

Learn More: Postpartum Endometritis→

Comprehensive Clinical Review

Structured, evidence-informed, long-form analysis for deeper understanding.

Evidence & Review

Reviewed by SymptomDx Medical Team · Last reviewed August 18, 2026

SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.